229 related articles for article (PubMed ID: 22723940)
1. Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.
Corsetti JP; Bakker SJ; Sparks CE; Dullaart RP
PLoS One; 2012; 7(6):e39110. PubMed ID: 22723940
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein.
Corsetti JP; Gansevoort RT; Bakker SJ; Navis G; Sparks CE; Dullaart RP
Metabolism; 2012 Jul; 61(7):996-1002. PubMed ID: 22225956
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling.
Corsetti JP; Love TM; Sparks CE; Bakker SJL; Dullaart RPF
Clin Biochem; 2018 Sep; 59():31-36. PubMed ID: 29928902
[TBL] [Abstract][Full Text] [Related]
4. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
[TBL] [Abstract][Full Text] [Related]
5. Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk.
Corsetti JP; Bakker SJL; Gansevoort RT; Gruppen EG; Connelly MA; Sparks CE; Dullaart RPF
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813431
[TBL] [Abstract][Full Text] [Related]
6. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism.
Ikewaki K; Rader DJ; Zech LA; Brewer HB
J Lipid Res; 1994 Oct; 35(10):1809-19. PubMed ID: 7852858
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Montali A; Vega GL; Grundy SM
Arterioscler Thromb; 1994 Apr; 14(4):511-7. PubMed ID: 8148349
[TBL] [Abstract][Full Text] [Related]
8. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype.
Mahley RW; Pépin J; Palaoğlu KE; Malloy MJ; Kane JP; Bersot TP
J Lipid Res; 2000 Aug; 41(8):1290-301. PubMed ID: 10946017
[TBL] [Abstract][Full Text] [Related]
9. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
10. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
11. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
12. Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.
Alexander ET; Phillips MC
J Lipid Res; 2013 Dec; 54(12):3464-70. PubMed ID: 24089247
[TBL] [Abstract][Full Text] [Related]
13. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
[TBL] [Abstract][Full Text] [Related]
14. Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.
Pedrini S; Doecke JD; Hone E; Wang P; Thota R; Bush AI; Rowe CC; Dore V; Villemagne VL; Ames D; Rainey-Smith S; Verdile G; Sohrabi HR; Raida MR; Taddei K; Gandy S; Masters CL; Chatterjee P; Martins RN;
J Neurochem; 2022 Oct; 163(1):53-67. PubMed ID: 36000528
[TBL] [Abstract][Full Text] [Related]
15. Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein.
Corsetti JP; Sparks CE; James RW; Bakker SJL; Dullaart RPF
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31480611
[TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II.
Hannuksela ML; Brousseau ME; Meyn SM; Nazih H; Bader G; Shamburek RD; Alaupovic P; Brewer HB
Atherosclerosis; 2002 Dec; 165(2):205-20. PubMed ID: 12417271
[TBL] [Abstract][Full Text] [Related]
17. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
[TBL] [Abstract][Full Text] [Related]
19. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
Taskinen MR; Barter PJ; Ehnholm C; Sullivan DR; Mann K; Simes J; Best JD; Hamwood S; Keech AC;
Diabetologia; 2010 Sep; 53(9):1846-55. PubMed ID: 20526762
[TBL] [Abstract][Full Text] [Related]
20. Characterization of high-density apolipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency.
Duverger N; Rader D; Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Nagano M; Nakamura H; Brewer HB
Eur J Biochem; 1995 Jan; 227(1-2):123-9. PubMed ID: 7851377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
